Multiple Sclerosis Drug Combats Vision Loss HealthDay via Yahoo! News Tue, 17 Apr 2007 6:00 AM PDT TUESDAY, April 17 (HealthDay News) -- A controversial multiple sclerosis drug called Tysabri also reduces vision loss associated with the disease by 47 percent, a new study found.

Multiple Sclerosis Drug Combats Vision Loss KOLD News 13 Tuscon Tue, 17 Apr 2007 6:38 AM PDT By Steven Reinberg , HealthDay Reporter TUESDAY, April 17 (HealthDay News) -- A controversial multiple sclerosis drug called Tysabri also reduces vision loss...

Multiple Sclerosis Drug Combats Vision Loss Health Scout Tue, 17 Apr 2007 7:15 AM PDT But doctors must weigh the potential risks of Tysabri, experts say.

Nutra Pharma Announces Successful Completion of Joint Venture Meetings in China RedNova Tue, 17 Apr 2007 9:00 AM PDT Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has today announced that its drug discovery division, ReceptoPharm, has successfully completed initial discussions with Zhong Xin Dong Tai Co., Ltd.

MS drug helps reduce vision loss EurekAlert! Mon, 16 Apr 2007 1:11 PM PDT ST. PAUL, Minn ? A drug that slows disability and reduces relapse rates in multiple sclerosis (MS) has been found to also reduce vision loss in patients with relapsing MS. Vision loss is one of the most common and debilitating symptoms of MS. The findings are published in the April 17, 2007, issue of Neurology?, the scientific journal of the American Academy of Neurology.

Penn researchers find treatment for MS also reduces vision loss in MS patients EurekAlert! Mon, 16 Apr 2007 1:23 PM PDT According to a study that appears in the April 17 issue of Neurology, researchers at the University of Pennsylvania School of Medicine have found that natalizumab (TYSABRI) -- a drug that slows disability and reduces relapse rates in patients with multiple sclerosis (MS) -- also reduces vision loss in patients with relapsing MS. Vision loss is one of the most common and disabling symptoms of MS.

MS Patients Not Receiving Medications to Slow Disease Progression Newswise Mon, 16 Apr 2007 11:20 AM PDT Neurologists at Wake Forest University Baptist Medical Center have found that many patients diagnosed with multiple sclerosis (MS) are not taking or being prescribed drugs approved to treat the disease.

Treatment for MS also Reduces Vision Loss in MS Patients Newswise Mon, 16 Apr 2007 2:21 PM PDT According to a study that appears in the April 17 issue of Neurology, researchers at the University of Pennsylvania School of Medicine have found that natalizumab (TYSABRI(r)) - a drug that slows disability and reduces relapse rates in patients with multiple sclerosis (MS) - also reduces vision loss in patients with relapsing MS.

PENN Medicine News: Penn Researchers Find Treatment for MS also Reduces Vision Loss in MS Patients
University of Pennsylvania Health System Mon, 16 Apr 2007 1:29 PM PDT
(PHILADELPHIA) ? According to a study that appears in the April 17 issue of Neurology , researchers at the University of Pennsylvania School of Medicine have found that natalizumab ( TYSABRI ?) ? a drug that slows disability and reduces relapse rates in patients with multiple sclerosis (MS) ? also reduces vision loss in patients with relapsing MS. Vision loss is one of the most common and ...